Edap Tms S.A. (EDAP) Scheduled to Post Earnings on Wednesday
Edap Tms S.A. (NASDAQ:EDAP) will be releasing its earnings data after the market closes on Wednesday, November 15th. Analysts expect Edap Tms to post earnings of $0.01 per share for the quarter.
Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). The firm had revenue of $10.40 million for the quarter, compared to analyst estimates of $10.00 million. Edap Tms had a negative net margin of 0.27% and a positive return on equity of 10.31%. Edap Tms’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.10 EPS. On average, analysts expect Edap Tms to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of Edap Tms S.A. (NASDAQ EDAP) opened at $3.07 on Tuesday. The stock has a market capitalization of $89.02, a price-to-earnings ratio of 73.00 and a beta of 1.05. Edap Tms S.A. has a 12-month low of $2.25 and a 12-month high of $3.85. The company has a current ratio of 2.96, a quick ratio of 2.35 and a debt-to-equity ratio of 0.11.
A number of research firms recently issued reports on EDAP. Zacks Investment Research cut Edap Tms from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 24th. HC Wainwright reissued a “buy” rating and set a $6.50 price objective on shares of Edap Tms in a research report on Friday, August 25th. Finally, ValuEngine raised Edap Tms from a “sell” rating to a “hold” rating in a research report on Friday, October 6th.
Edap Tms Company Profile
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.